Capital Innovations’s Mead Johnson Nutrition Company MJN Stock Holding History

Capital Innovations’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,200	Closed	-$226K	–	59
2016 Q4	$226K	Sell	3,200 -960	-23%	-$71.5K	1.26%	38
2016 Q3	$329K	Buy	4,160 +460	+12%	+$39.2K	0.82%	49
2016 Q2	$336K	Sell	3,700 -845	-19%	-$71.6K	0.98%	42
2016 Q1	$386K	Sell	4,545 -510	-10%	-$37.9K	0.68%	45
2015 Q4	$399K	Buy	5,055 +1,570	+45%	+$124K	0.52%	47
2015 Q3	$245K	Sell	3,485 -1,178	-25%	-$96.9K	0.28%	81
2015 Q2	$421K	Sell	4,663 -310	-6%	-$29.9K	0.41%	61
2015 Q1	$500K	Hold	4,973	–	–	0.43%	59
2014 Q4	$500K	Buy	4,973 +720	+17%	+$71.8K	0.44%	57
2014 Q3	$409K	Buy	4,253 +1,648	+63%	+$156K	0.38%	65
2014 Q2	$243K	Buy	+2,605	New	+$228K	0.2%	75

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Innovations's MJN Position: Q1 2017 in Review

Capital Innovations sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 3,200 shares — an estimated $226K sold.

Capital Innovations first reported a position in MJN in Q2 2014 and held it in 11 quarters. The position peaked at $500K in Q1 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Capital Innovations reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Capital Innovations sold 3,200 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $226K.
Capital Innovations first reported a position in Mead Johnson Nutrition Company in Q2 2014 and held it in 11 quarters.
Capital Innovations's Mead Johnson Nutrition Company position peaked at $500K in Q1 2015.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Capital Innovations's 13F filing for Q1 2017, filed 5 May 2017.